Source: Annual Congress 2002 - Aspects of bronchopulmonary dysplasia
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Hendriks, M. de Hoog, M. Lequin, J. C. de Jongste, P. J. F. M. Merkus (Rotterdam, The Netherlands). DNase treatment for atelectasis in non-CF pediatric patients. Eur Respir J 2002; 20: Suppl. 38, 3475

Member's Comments

No comment yet.

Related content which might interest you: Prognostic indicators of adult patients with non-CF bronchiectasis and those with combined COPD and non-CF bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Immunomodulative therapy in young patients with non-CF bronchiectases exacerbations Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood Year: 2009 Factors associated with the need of intravenous antibiotics in a cohort of adult patients with non-CF bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Inpatient management of non-CF bronchiectasis: Should patients be managed as in CF? Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 The surgical treatment of lung bronchiectasis. Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease Year: 2020 Time to diagnosis and adherence to guidelines in a large cohort of patients with non-CF bronchiectasis Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Lobar atelectasis in cystic fibrosis and treatment with bronchoscopically administered DNase Source: Eur Respir J 2003; 22: Suppl. 45, 429s Year: 2003 Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Non invasive ventilation (NIV) assists chest physiotherapy for treatment of patients with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 The evaluation of 239 patients with bronchiectasis who had surgical therapy Source: Annual Congress 2006 - Surgery for chronic benign disease and management of complications Year: 2006 Aerozolized colistin therapy in non-cystic fibrosis patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001 Challenges in the management of non-CF bronchiectasis Source: International Congress 2016 – Challenges in the management of non-CF bronchiectasis Year: 2016 Azithromycin, a novel maintenance therapy in patients with chronic non-CF suppurative lung disease Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Paratracheal air cysts in patients with non-CF bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Long-term macrolide therapy for non-CF bronchiectasis Source: Annual Congress 2013 –ERS/JAMA Lunchtime session "Advances in IPF, bronchiectasis and sarcoidosis" Year: 2013 Comparison of costs of community-acquired pneumonia (CAP) treatment at patients with and without bronchial obstruction Source: Annual Congress 2011 - COPD management Year: 2011 Accompanying asthma in cystic fibrosis (CF) and non-CF bronchiectatic patients: could we detect it with AMP bronchoprovocation and sputum properties? Source: Eur Respir J 2007; 30: Suppl. 51, 374s Year: 2007 The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015